T/R ratio for estimation of sample size in BE study of NTI drugs [Power / Sample Size]

posted by nobody – 2017-10-26 16:03 (3155 d 11:16 ago) – Posting: # 17921
Views: 9,143

...to be true: I would support discouraging the use of defaults without any knowledge on the actual products (dissolution, pharmaceutical quality etc.). Planning a BE-study should involve that you know that the "correct" GMR / sample size is hindsight knowledge and one way or the other there is a risk to loose money (too many volunteers, too little power to conclude BE), one way ore the other... :-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
176 visitors (0 registered, 176 guests [including 32 identified bots]).
Forum time: 03:20 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5